Deep Visual Proteomics defines single-cell identity and heterogeneity

  • Nat Biotechnol. 2022 Aug;40(8):1231-1240. doi: 10.1038/s41587-022-01302-5.
Andreas Mund  #  1 ,  Fabian Coscia  #  2  3 ,  András Kriston  4  5 ,  Réka Hollandi  4 ,  Ferenc Kovács  4  5 ,  Andreas-David Brunner  6 ,  Ede Migh  4 ,  Lisa Schweizer  6 ,  Alberto Santos  2  7  8 ,  Michael Bzorek  9 ,  Soraya Naimy  9 ,  Lise Mette Rahbek-Gjerdrum  9  10 ,  Beatrice Dyring-Andersen  2  11  12 ,  Jutta Bulkescher  13 ,  Claudia Lukas  13  14 ,  Mark Adam Eckert  15 ,  Ernst Lengyel  15 ,  Christian Gnann  16 ,  Emma Lundberg  16  17  18 ,  Peter Horvath  19  20  21 ,  Matthias Mann  22  23
Affiliations
  • 1. Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. [email protected].
  • 2. Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • 3. Spatial Proteomics Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • 4. Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
  • 5. Single-Cell Technologies Ltd., Szeged, Hungary.
  • 6. Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • 7. Center for Health Data Science, University of Copenhagen, Copenhagen, Denmark.
  • 8. Big Data Institute, Li-Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.
  • 9. Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • 10. Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • 11. Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • 12. Leo Foundation Skin Immunology Research Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • 13. Protein Imaging Platform, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • 14. Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • 15. Department of Obstetrics and Gynecology/Section of Gynecologic Oncology, University of Chicago, Chicago, IL, USA.
  • 16. Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • 17. Department of Bioengineering, Stanford University, Stanford, CA, USA.
  • 18. Chan Zuckerberg Biohub, San Francisco, CA, USA.
  • 19. Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary. [email protected].
  • 20. Single-Cell Technologies Ltd., Szeged, Hungary. [email protected].
  • 21. Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. [email protected].
  • 22. Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. [email protected].
  • 23. Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. [email protected].
  • # Contributed equally.
Abstract

Despite the availabilty of imaging-based and mass-spectrometry-based methods for spatial proteomics, a key challenge remains connecting images with single-cell-resolution protein abundance measurements. Here, we introduce Deep Visual Proteomics (DVP), which combines artificial-intelligence-driven image analysis of cellular phenotypes with automated single-cell or single-nucleus laser microdissection and ultra-high-sensitivity mass spectrometry. DVP links protein abundance to complex cellular or subcellular phenotypes while preserving spatial context. By individually excising nuclei from Cell Culture, we classified distinct cell states with proteomic profiles defined by known and uncharacterized proteins. In an archived primary Melanoma tissue, DVP identified spatially resolved proteome changes as normal melanocytes transition to fully invasive Melanoma, revealing pathways that change in a spatial manner as Cancer progresses, such as mRNA splicing dysregulation in metastatic vertical growth that coincides with reduced interferon signaling and antigen presentation. The ability of DVP to retain precise spatial proteomic information in the tissue context has implications for the molecular profiling of clinical samples.